€14 Million Boost: Evaro Revolutionizes Digital Clinics for Brands

Evaro, a UK-based digital health startup, has secured €1.4 million in seed funding to create digital clinics for consumer brands. The funding round was led by Cornerstone VC and Exceptional Ventures, with participation from other investors. Evaro will use the funding to expand its offering to the B2B market, enabling consumer brands to offer managed medication prescription services to their customers. The company was founded in 2018 and aims to provide scalable, safe, and affordable care to people in the UK through a self-service model focused on routine health needs. Evaro stands out in the digital health space by offering a “pharmaceutical infrastructure as a service” to consumer brands, allowing them to expand their offering and increase consumer engagement. The company uses AI and machine learning to provide access to consultations and prescription medication. The funding will enable Evaro to grow its medication catalogue and acquire a Care Quality Commission license to provide more comprehensive patient care.